Anders L Carlson MD
Diabetes, Lipid Metabolism
Assistant Professor, Medicine, University of Minnesota Medical School, Minneapolis
Join to View Full Profile
1665 Utica Ave SSte 100Saint Louis Park, MN 55416
Phone+1 952-541-2500
Dr. Carlson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2010
Hennepin HealthcareResidency, Internal Medicine, 2005 - 2008
University of Minnesota Medical SchoolClass of 2005
Certifications & Licensure
MN State Medical License 2010 - 2025
WI State Medical License 2010 - 2017
VT State Medical License 2008 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase Start of enrollment: 2019 Oct 23
Publications & Presentations
PubMed
- Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in Pregnancy.Anders L Carlson, Roy W Beck, Zoey Li, Elizabeth Norton, Richard M Bergenstal
Diabetes Technology & Therapeutics. 2025-04-02 - Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Compar...Kristina M Utzschneider, Mark Tripputi, Nicole M Butera, Andrea Mari, Samuel P Rosin
Diabetes Care. 2025-04-01 - Primary Care and Diabetes Technologies and Treatments.Gregg D Simonson, Thomas W Martens, Anders L Carlson, Richard M Bergenstal
Diabetes Technology & Therapeutics. 2025-03-01
Journal Articles
- Fast‐Acting Insulin Aspart Versus Insulin Aspart in the Setting of Insulin Degludec‐Treated Type 1 Diabetes: Efficacy and Safety from a Randomized Double‐Blind TrialJohn B Buse, Anders L Carlson, Diabetes, Obesity and Metabolism
Press Mentions
Should ‘Time in Tight Range’ Be the Primary Diabetes Goal?March 25th, 2025- Remote Diabetes Management Using CGM and Telemedicine Visits Can Improve Glycemic ControlSeptember 22nd, 2021
- Medtronic Touts Trial Results for InPen Smart Insulin Pen, Extended Infusion SystemJune 28th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
